{"text": ["How", "Eli", "Lilly\u2019s", "Business", "Segments", "Performed", "in", "Q2", "2018"], "created_at": "2018-08-31 18:05:10"}
{"text": ["Glaxo's", "Asthma", "Drug", "Gets", "EU", "Nod", "for", "Pediatric", "Population"], "created_at": "2018-08-31 17:57:09"}
{"text": ["Glaxo's", "Asthma", "Drug", "Gets", "EU", "Nod", "for", "Pediatric", "Population"], "created_at": "2018-08-31 17:57:09"}
{"text": ["Analyzing", "Eli", "Lilly\u2019s", "Q2", "2018", "Revenue", "Trend"], "created_at": "2018-08-31 16:35:10"}
{"text": ["Glaxo&apos;s", "Asthma", "Drug", "Gets", "EU", "Nod", "for", "Pediatric", "Population"], "created_at": "2018-08-31 15:42:03"}
{"text": ["Eli", "Lilly\u2019s", "Valuation", "on", "August", "30"], "created_at": "2018-08-31 15:02:12"}
{"text": ["Biotech", "Stocks", "Facing", "FDA", "Decision", "In", "September"], "created_at": "2018-08-31 06:05:00"}
{"text": ["Biotech", "Stocks", "Facing", "FDA", "Decision", "In", "September"], "created_at": "2018-08-31 06:05:00"}
